How AI helped find a treatment for a newborn with an ultra rare disease

In the early weeks of her life, Jorie Kraus suffered severe muscle and developmental issues that threatened her life, affecting her heart, legs, and breathing.
A long-shot genomic sequencing approach and the use of the AI tool Biomedical Data Translator led to the discovery that a common drug, Klonopin, could treat her ultra-rare condition caused by a gene deletion.
The introduction of Klonopin led to a dramatic improvement in Jorie’s condition, as detailed by her mother, who described an almost miraculous transformation.
The process of identifying the drug involved overcoming multiple barriers, including the limited availability of genomic sequencing and difficulties in rapid treatment confirmation, but critical insights came from the AI tool.
Jorie’s parents created the Jorie Effect organization to support children with similar conditions, with its first success story being a five-year-old child who started speaking after being prescribed Klonopin based on Jorie’s treatment.
Despite the emotional difficulty, Jorie’s parents believe sharing their story is essential to offer hope and support to other parents facing similar struggles and to advocate for the broader use of the technologies that saved Jorie’s life.

You may have missed